US Stock MarketDetailed Quotes
MBIO Mustang Bio
- 0.3209
- -0.0192-5.65%
Close Jul 19 16:00 ET
- 0.3100
- -0.0109-3.40%
Pre 08:26 ET
11.05MMarket Cap-72P/E (TTM)
0.3500High0.3201Low1.43MVolume0.3401Open0.3401Pre Close477.31KTurnover4.61%Turnover RatioLossP/E (Static)34.43MShares5.475052wk High-2.23P/B9.93MFloat Cap0.128152wk Low--Dividend TTM30.94MShs Float200.2500Historical High--Div YieldTTM8.79%Amplitude0.1281Historical Low0.3340Avg Price1Lot Size
Mustang Bio Key Stats
Quarterly+Annual
YOY
| (Q2)Mar 31, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 70.12%-5.32M | 23.96%-49.48M | 52.55%-7.25M | 24.45%-12.02M | 29.49%-12.39M | -9.33%-17.81M | -21.24%-65.07M | -3.99%-15.29M | -40.96%-15.91M | |
| Net income from continuing operations | ---- | 68.90%-5.19M | 33.44%-51.6M | 56.12%-8.62M | 47.05%-10.06M | 15.00%-16.24M | 15.67%-16.69M | -16.81%-77.53M | 2.07%-19.63M | -11.71%-19M |
| Operating gains losses | ---- | ---- | 421.57%1.33M | ---115K | -8,543.75%-1.35M | ---- | ---- | --255K | --0 | --16K |
| Depreciation and amortization | ---- | -18.88%696K | -26.59%2.23M | -56.47%363K | -55.19%367K | -8.87%637K | 26.36%858K | 31.44%3.03M | 20.52%834K | 33.82%819K |
| Other non cash items | ---- | ---- | -65.80%978K | -34.88%1.03M | -73.50%53K | -201.66%-245K | -83.02%143K | -62.98%2.86M | -64.44%1.58M | -71.63%200K |
| Change In working capital | ---- | 61.63%-902K | -173.85%-2.98M | -106.91%-101K | -173.02%-1.13M | 300.00%610K | -277.97%-2.35M | 732.65%4.03M | 320.69%1.46M | -55.82%1.55M |
| -Change in receivables | ---- | -8,041.67%-2.86M | -357,900.00%-3.58M | -19,988.89%-3.62M | --0 | --0 | 100.00%36K | 97.14%-1K | -100.00%-18K | --0 |
| -Change in prepaid assets | 1,744,456.19%3.38B | 183.21%371K | 208.55%1.09M | 7,822.22%2.78M | -94.12%-2.01M | 236.62%194K | -37.32%131K | -150.87%-1.01M | 96.78%-36K | -363.87%-1.04M |
| -Change in payables and accrued expense | ---- | 181.46%2.02M | -96.38%192K | -19.49%1.25M | -63.80%957K | 688.46%459K | -310.01%-2.48M | 3,128.57%5.3M | 185.85%1.56M | -9.95%2.64M |
| -Change in other current assets | --485.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | 7,677,216.28%3.3B | -926.19%-431K | -158.56%-680K | -1,192.50%-517K | -44.44%-78K | 48.81%-43K | 50.59%-42K | 11.15%-263K | 49.37%-40K | 28.00%-54K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---- | 70.12%-5.32M | 23.96%-49.48M | 52.55%-7.25M | 24.45%-12.02M | 29.49%-12.39M | -9.33%-17.81M | -21.24%-65.07M | -3.99%-15.29M | -40.96%-15.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 448.19M | 299.39%5.89M | 92.86%-30K | 767.04%5.95M | 44.99%-2.95M | 71.56%-420K | 9.90%-892K | |||
| Net PPE purchase and sale | ---- | ---- | 329.45%5.94M | 68.42%-30K | 804.23%6M | ---- | ---- | 35.10%-2.59M | 93.10%-95K | -85.22%-852K |
| Net intangibles purchase and sale | ---- | ---- | 86.30%-50K | --0 | ---- | ---- | ---- | 73.55%-365K | -225.00%-325K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | 299.39%5.89M | 92.86%-30K | 767.04%5.95M | 88.89%-34K | --0 | 44.99%-2.95M | 71.56%-420K | 9.90%-892K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 49K | -176.59%-26.08M | 395,400.00%3.96M | -68.75%250K | -1,098.25%-30.29M | 0 | -51.93%34.06M | -99.98%1K | -75.27%800K | |
| Net issuance payments of debt | ---- | ---- | -201.25%-30.38M | --0 | --0 | ---- | ---- | --30M | --0 | --0 |
| Net common stock issuance | ---- | ---- | -31.13%4.56M | 439,700.00%4.4M | -77.42%163K | ---- | ---- | -90.79%6.62M | -99.98%1K | -77.00%722K |
| Proceeds from stock option exercised by employees | ---- | --49K | -13.59%178K | --0 | 0.00%90K | --88K | --0 | -33.33%206K | --0 | -40.40%90K |
| Net other financing activities | ---- | ---- | 83.95%-445K | ---442K | ---- | ---- | ---- | -100.80%-2.77M | --0 | 78.18%-12K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | --49K | -176.58%-26.08M | 395,500.00%3.96M | -68.75%250K | -1,098.25%-30.29M | --0 | -51.93%34.06M | -99.98%1K | -75.27%800K |
| Net cash flow | ||||||||||
| Beginning cash position | ---- | -90.89%6.98M | -30.70%76.66M | -88.84%10.31M | -85.11%16.14M | -52.24%58.85M | -30.70%76.66M | 11.96%110.62M | -24.22%92.36M | -17.23%108.37M |
| Current changes in cash | ---- | 70.40%-5.27M | -105.15%-69.67M | 78.81%-3.33M | 63.62%-5.82M | -187.69%-42.71M | -241.36%-17.81M | -387.47%-33.96M | -39.49%-15.71M | -76.97%-16.01M |
| End cash Position | ---- | -97.09%1.71M | -90.89%6.98M | -90.89%6.98M | -88.84%10.31M | -85.11%16.14M | -52.24%58.85M | -30.70%76.66M | -30.70%76.66M | -24.22%92.36M |
| Free cash flow | ---- | 70.12%-5.32M | 27.23%-49.59M | 53.63%-7.28M | 28.70%-12.07M | 30.51%-12.43M | -1.05%-17.81M | -15.44%-68.15M | 2.91%-15.71M | -37.89%-16.93M |
| Currency Unit | JPY | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg